logo

For the Inventor, By the Inventor

Philadelphia, PA, United States of America

Alan M Gewirtz

This inventor holds 11 USPTO granted patents. Top assignees: University of Pennsylvania, Temple University, Johns Hopkins University. Active years: 1992-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alan M Gewirtz. Retrieved from https://idiyas.com/inventor/alan-m-gewirtz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 100.0

Average Co-Inventor Count = 1.5

ph-index = 7

Forward Citations = 245(Granted Patents)


Location History:

  • Philadelphia, PA (US) (1992 - 1999)
  • Narberth, PA (US) (2001)
  • Penn Valley, PA (US) (2010)

Company Filing History:

goldMedal6 out of 2,659 
 
University of Pennsylvania
 patents
silverMedal5 out of 423 
 
Temple University
 patents
bronzeMedal1 out of 3,801 
 
Johns Hopkins University
 patents
4. 1 out of 300 
 
The Children's Hospital of Philadelphia
 patents
where one patent can have more than one assignee

Years Active: 1992-2010

Loading Chart...
11 patents (USPTO):Explore Patents
1. 7851452 - Methods of use of bcl-6-derived nucleotides to induce apoptosis (2010-12-14),
2. 6218186 - HIV-MSCV hybrid viral vector for gene transfer (2001-04-17),
3. 5989849 - Antisense of oligonucleotides to c-kit proto-oncogene and in vitro (1999-11-23),
4. 5652222 - Selective inhibition of leukemic cell proliferation by bcr-abl antisense (1997-07-29),
5. 5618709 - Antisense oligonucleotides specific for STK-1 and method for inhibiting (1997-04-08),
6. 5612212 - Selective inhibition of cell proliferation by vav antisense (1997-03-18),
7. 5472944 - Suppression of megakaryocytopoiesis by neutrophil activating peptide-2 (1995-12-05),
8. 5427916 - Method for predicting the effectiveness of antineoplastic therapy in (1995-06-27),
9. 5306709 - Suppression of megakaryocytopoiesis by macrophage inflammatory proteins (1994-04-26),
10. 5185323 - Suppression of megakaryocytopoiesis employing platelet factor 4 (1993-02-09),
11. 5098890 - Antisence oligonucleotides to c-myb proto-oncogene and uses thereof (1992-03-24),
Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…